山东罗欣药业集团股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
297
NMPA:297
Drug Approvals
Ibuprofen Concentrated Solution for Injection
- Product Name
- 布洛芬注射用浓溶液
- Approval Number
- 国药准字H20254221
- Approval Date
- May 20, 2025
NMPA
Glutathione for Injection
- Product Name
- 注射用谷胱甘肽
- Approval Number
- 国药准字H20193127
- Approval Date
- Apr 23, 2024
NMPA
Glutathione for Injection
- Product Name
- 注射用谷胱甘肽
- Approval Number
- 国药准字H20193131
- Approval Date
- Apr 23, 2024
NMPA
Glutathione for Injection
- Product Name
- 注射用谷胱甘肽
- Approval Number
- 国药准字H20193129
- Approval Date
- Apr 23, 2024
NMPA
Glutathione for Injection
- Product Name
- 注射用谷胱甘肽
- Approval Number
- 国药准字H20193130
- Approval Date
- Apr 23, 2024
NMPA
Glutathione for Injection
- Product Name
- 注射用谷胱甘肽
- Approval Number
- 国药准字H20193128
- Approval Date
- Apr 23, 2024
NMPA
Phenazopyridine Hydrochloride Tablets
- Product Name
- 盐酸非那吡啶片
- Approval Number
- 国药准字H20094071
- Approval Date
- Mar 21, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 30
- Next
Clinical Trials
No trials found
News
No news found